|
End-of-day quote
NSE India S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 1,869.40 INR | -0.48% |
|
+0.34% | +37.00% |
| 08-06 | Emcure Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 06, 2026 | |
| 08-06 | Emcure Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.48% | +0.34% | -2.17% | +10.22% | +37.00% | +34.16% | - | - | - | 3.71B | |
| -0.13% | -6.44% | +1.70% | +6.30% | +9.30% | +60.34% | +114.35% | +347.79% | +1,410.36% | 1,047B | |
| +0.85% | -0.81% | +4.78% | +18.95% | +29.52% | +51.29% | +63.71% | +54.35% | +124.36% | 646B | |
| -1.03% | -3.58% | -0.75% | +17.34% | +11.81% | +21.43% | +72.25% | +111.89% | +298.19% | 451B | |
| -0.88% | -4.08% | +0.48% | +11.94% | +8.26% | +36.55% | +36.50% | -3.39% | +48.17% | 355B | |
| -0.34% | -2.68% | -2.56% | +8.31% | +12.55% | +21.49% | +38.13% | +45.49% | +59.38% | 291B | |
| -1.19% | -2.21% | -5.90% | -13.27% | -13.20% | +1.53% | +11.51% | +39.75% | +139.30% | 252B | |
| -1.05% | -1.57% | +11.55% | +28.39% | +32.11% | +50.30% | +67.68% | +92.93% | +153.23% | 234B | |
| -1.20% | -2.47% | -4.78% | +2.44% | -10.27% | -20.06% | -54.18% | -7.01% | +86.66% | 203B | |
| -2.14% | -0.30% | +10.97% | +8.37% | +18.69% | +28.95% | +87.59% | +102.31% | +86.96% | 181B | |
| -0.21% | -0.39% | +12.24% | +6.80% | +12.29% | +12.92% | -22.12% | -40.21% | -19.84% | 159B | |
| -1.07% | -1.16% | +12.45% | +21.04% | +19.48% | +38.53% | +54.43% | +171.54% | +465.44% | 137B | |
| -0.55% | -0.64% | +2.65% | +16.44% | +23.43% | +41.12% | +6.73% | -0.94% | +16.32% | 136B | |
| -0.22% | -1.53% | +3.50% | +3.94% | -6.82% | -8.99% | -21.86% | -12.03% | +11.60% | 107B | |
| +0.08% | -3.39% | -4.46% | -1.49% | +1.59% | +27.61% | +32.62% | +0.49% | -9.83% | 101B | |
| -1.71% | -1.06% | -0.27% | -9.80% | -16.13% | +6.03% | +55.10% | +60.47% | +539.11% | 72.33B | |
| -0.60% | -0.55% | +4.57% | +18.11% | +19.23% | +29.00% | +27.88% | +56.70% | +26.43% | 57.89B | |
| +0.36% | +0.62% | +1.52% | +38.86% | +31.80% | +75.09% | -3.48% | +3.47% | -49.17% | 55.49B | |
| -0.61% | -0.88% | -13.41% | -5.72% | -20.56% | -28.55% | +12.27% | +3.77% | +195.00% | 46.32B | |
| -0.35% | +1.40% | -0.11% | +9.36% | -1.76% | +1.46% | +13.08% | - | - | 43.98B | |
| Average | -0.67% | -1.31% | +1.60% | +9.83% | +9.92% | +24.01% | +31.17% | +57.08% | +198.98% | 228.99B | |
| Weighted average by Cap. | -0.59% | -2.90% | +2.15% | +10.43% | +11.85% | +34.59% | +55.38% | +117.91% | +428.10% |
- Stock Market
- Stocks
- EMCURE Stock
- Sector Emcure Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
